Stockreport

Astellas' VYLOY™ (zolbetuximab-clzb) Approved by U.S. FDA for Treatment of Advanced Gastric and GEJ Cancer [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO Oct. 18, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 450 [Read more]